FIL1L (FILIP1L)
(Filamin A Interacting Protein 1-Like (FILIP1L))
Protein Region
Middle Region
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-FILIP1L antibody (Catalog #: ARP52360_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
FIL1L (FILIP1L)
(Filamin A Interacting Protein 1-Like (FILIP1L))
Synonyme
DOC-1 Peptide, DOC1 Peptide, GIP130 Peptide, GIP130a Peptide, GIP130b Peptide, GIP130c Peptide, GIP90 Peptide, 4631422O05Rik Peptide, Doc1 Peptide, FILIP1L Peptide, filamin A interacting protein 1 like Peptide, filamin A interacting protein 1-like Peptide, FILIP1L Peptide, Filip1l Peptide, filip1l Peptide
Hintergrund
FILIP1L acts as a regulator of the antiangiogenic activity on endothelial cells. When overexpressed in endothelial cells, FILIP1L leads to inhibition of cell proliferation and migration and an increase in apoptosis. FILIP1L inhibits melanoma growth when e
Alias Symbols: DOC-1, DOC1, GIP90, GIP130, GIP130a, GIP130b, GIP130c